Cargando…

MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal Osteoporosis

BACKGROUND: Osteoporosis mainly occurs in postmenopausal women, which is characterized by low bone mineral density (BMD) due to unbalanced bone resorption by osteoclasts and formation by osteoblasts. Circulating monocytes play important roles in osteoclastogenesis by acting as osteoclast precursors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yang, Li, Ling, Moore, Benjamin T., Peng, Xian-Hao, Fang, Xiang, Lappe, Joan M., Recker, Robert R., Xiao, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323546/ https://www.ncbi.nlm.nih.gov/pubmed/22506038 http://dx.doi.org/10.1371/journal.pone.0034641

Ejemplares similares

MiR-422a as a Potential Cellular MicroRNA Biomarker for Postmenopausal Osteoporosis
por: Cao, Zheng, et al.
Publicado: (2014)

Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
por: Shen, Jie, et al.
Publicado: (2014)

Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s Disease
por: Zhang, Xiong, et al.
Publicado: (2017)

Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis
por: Meng, Jia, et al.
Publicado: (2015)

Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis
por: Xu, Jixi, et al.
Publicado: (2022)

MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis
por: Shi, Hongli, et al.
Publicado: (2022)

Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis
por: Ding, Haifeng, et al.
Publicado: (2017)

Identification and evaluation of circulating exosomal miRNAs for the diagnosis of postmenopausal osteoporosis
por: Sun, Zhibang, et al.
Publicado: (2023)

Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis
por: Lin, Chujiao, et al.
Publicado: (2019)

Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction
por: Peng, Liu, et al.
Publicado: (2014)

Circulating MiR-133a as a Biomarker Predicts Cardiac Hypertrophy in Chronic Hemodialysis Patients
por: Wen, Ping, et al.
Publicado: (2014)

Differentially expressed circulating miRNAs in postmenopausal osteoporosis: a meta-analysis
por: Pala, Elif, et al.
Publicado: (2019)

Circulating miR-340-5p and miR-506-3p as Two Osteo-miRNAs for Predicting Osteoporosis in a Cohort of Postmenopausal Women
por: Lu, Zifeng, et al.
Publicado: (2023)

Variables Reflecting the Mineralization of Bone Tissue From Fracturing Versus Nonfracturing Postmenopausal Nonosteoporotic Women
por: Rizzo, Sébastien, et al.
Publicado: (2018)

Retracted: Circulating miR-340-5p and miR-506-3p as Two Osteo-miRNAs for Predicting Osteoporosis in a Cohort of Postmenopausal Women
por: Environmental and Public Health, Journal of
Publicado: (2023)

Quantification of aminobutyric acids and their clinical applications as biomarkers for osteoporosis
por: Wang, Zhiying, et al.
Publicado: (2020)

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b
por: Coccia, Elena, et al.
Publicado: (2020)

Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients
por: Deng, Yi-Xuan, et al.
Publicado: (2022)

MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA
por: Yu, Tao, et al.
Publicado: (2020)

Smad8 Is Increased in Duchenne Muscular Dystrophy and Suppresses miR-1, miR-133a, and miR-133b
por: Lopez, Michael A., et al.
Publicado: (2022)

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
por: Koutsoulidou, Andrie, et al.
Publicado: (2011)

Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients
por: Zhang, Peng, et al.
Publicado: (2023)

Identification of gene biomarkers in patients with postmenopausal osteoporosis
por: Yang, Chenggang, et al.
Publicado: (2019)

Age-Related Exosomal and Endogenous Expression Patterns of miR-1, miR-133a, miR-133b, and miR-206 in Skeletal Muscles
por: Mytidou, Chrystalla, et al.
Publicado: (2021)

MiR-210 improves postmenopausal osteoporosis in ovariectomized rats through activating VEGF/Notch signaling pathway
por: Ren, Li-Jue, et al.
Publicado: (2023)

Construction of an miRNA-Regulated Pathway Network Reveals Candidate Biomarkers for Postmenopausal Osteoporosis
por: Shao, Min
Publicado: (2017)

The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism
por: Chen, Yao-ping, et al.
Publicado: (2016)

Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s disease
por: Chen, Qihua, et al.
Publicado: (2021)

Longitudinal Changes of Circulating miRNAs During Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal Osteoporosis
por: Weigl, Moritz, et al.
Publicado: (2021)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

MiR-133 is Involved in Estrogen Deficiency-Induced Osteoporosis through Modulating Osteogenic Differentiation of Mesenchymal Stem Cells
por: Lv, Hao, et al.
Publicado: (2015)

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
por: McClung, M. R., et al.
Publicado: (2012)

Obesity-induced inflammatory miR-133a mediates apoptosis of granulosa cells and causes abnormal folliculogenesis: Role of miR-133a in folliculogenesis
por: Chen, Ruizhi, et al.
Publicado: (2023)

Expression of miR‐18a and miR‐34c in circulating monocytes associated with vulnerability to type 2 diabetes mellitus and insulin resistance
por: Wang, Si‐Si, et al.
Publicado: (2017)

Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies
por: Lubkowska, Anna, et al.
Publicado: (2014)

FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis
por: Yang, Weiwei, et al.
Publicado: (2022)

Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease
por: Kumar, Dinesh, et al.
Publicado: (2020)

Aberrant expression of miR-33a-3p/IGF2 in postmenopausal osteoporosis patients and its role and mechanism in osteoporosis
por: Wang, Changxin, et al.
Publicado: (2023)

Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis—the MiDeTe study
por: Messner, Zora, et al.
Publicado: (2022)

Overexpression of miR125b Promotes Osteoporosis Through miR-125b-TRAF6 Pathway in Postmenopausal Ovariectomized Rats
por: Wang, Gang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_un25o7nu814blufcpjpg5acnap